Target intelligence / Profile preview

T-cell receptor recognizing Mucor racemosus-derived peptides (Mucor-specific TCR)

Target
Mucor-specific TCR
Molecular classification
Receptor, T-cell receptor, Immune system receptor
01

Overview

The T-cell receptor (TCR) recognizing Mucor racemosus-derived peptides is a specialized immune receptor found on the surface of T-lymphocytes that specifically identifies antigenic fragments from the Mucorales order of fungi. These receptors play a critical role in the adaptive immune response by binding to fungal peptides presented by major histocompatibility complex (MHC) molecules on antigen-presenting cells. Upon recognition, the TCR triggers T-cell activation, leading to the proliferation of fungus-specific effector cells and the secretion of pro-inflammatory cytokines like interferon-gamma and IL-17, which are essential for controlling invasive fungal growth. In the context of disease, these TCRs are vital for defense against mucormycosis, a life-threatening infection that primarily affects immunocompromised individuals, such as those undergoing hematopoietic stem cell transplantation or chemotherapy. Research into these specific receptors is driving the development of adoptive T-cell therapies, where T-cells are enriched or engineered to express these TCRs to restore antifungal immunity in vulnerable patients. While promising, therapeutic application requires careful monitoring for potential complications such as graft-versus-host disease or excessive inflammatory responses.

Other names
Mucor-reactive T-cell receptorMucorales-specific T-cell receptorT-cell receptor recognizing Mucorales antigens
02

Mechanism of action

Adoptive transfer of T-cells engineered with specific T-cell receptors to recognize and eliminate fungal pathogens through direct cytotoxicity and cytokine-mediated immune coordination.

03

Biological functions

Immune responseAntigen recognitionT-cell activationCytokine productionAntifungal immunity
04

Disease associations

InfectionMucormycosisInvasive fungal infectionImmunodeficiency
05

Safety considerations

Graft-versus-host disease (in allogeneic settings)Cytokine release syndromeOff-target reactivityImmune-mediated tissue damage
06

Interacting drugs

Adoptive T-cell therapy (investigational)

1 more in the full profile.

07

Biomarkers

Mucor-specific T-cell frequencyInterferon-gamma productionCD154 expression on T-cells

Beyond the preview

Go deeper on T-cell receptor recognizing Mucor racemosus-derived peptides (Mucor-specific TCR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T-cell receptor recognizing Mucor racemosus-derived peptides (Mucor-specific TCR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call